Search results
...0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor... Advanced Merkel Cell Carcinoma...
Morningstar· 2 days ago("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy and Kintara ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days ago(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics..
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 days agoThe rolling BLA submission, initiated in December 20233 with timelines pre-agreed with the FDA, was based on Telix’s successful global Phase III ZIRCON4 study in ccRCC. The clear cell ...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Zacks via Yahoo Finance· 13 hours agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 5 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
...Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination... Treatment of Colon Cancer...
The Grass Valley Union· 2 days agoThe...
Molecular Templates reports progress in cancer therapy trials By Investing.com
Investing.com· 2 days agoMolecular Templates, Inc. (NASDAQ:MTEM), a clinical-stage biopharmaceutical company, has announced...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 2 days agoThe study is evaluating mRNA-4157 (V940), an investigational individualized neoantigen therapy...
Ironman Athlete Patricia Salazar Says Surviving Cervical Cancer 'Gave Me Confidence' (Exclusive)
People via Yahoo News· 5 days ago“The people currently in the 30-year-old range are...Extramural Discovery Science at the American ...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 5 days agoA Phase 3 study is already underway with the initial results expected later this decade. But at...
